Skip to content
Search

Latest Stories

Lord Bilimoria’s lenders set to receive payout as his Cobra beer business gets £2.3m dividend

He promised to repay his debts from his share of dividends after his business was revived in 2009

Lord Bilimoria’s lenders set to receive payout as his Cobra beer business gets £2.3m dividend

Lenders to Lord Karan Bilimoria are on course to receive a payout from a £2.3 million dividend he received from his Cobra beer business last year.

The current vice president of the Confederation of British Industry (CBI) owed £70m to his 340 creditors when Cobra Beer collapsed in 2009, some 20 years after he founded the company in Fulham.

However, the Hyderabad-born British Indian entrepreneur struck a pre-pack deal with the American brewer Molson Coors to revive the business and formed the joint venture, Cobra Beer Partnership.

He made a widely praised commitment to his creditors to repay his debts from his share of dividends from the business. The 10-year joint venture in which he has a 49.9 per cent stake was extended in 2019. He heads the collaboration as the chairman.

Filings with the registrar of companies said the joint venture declared a dividend of £4.6 million for 2021 and half of it - £2.3 million - being the peer’s share. This was down compared to the £3 million he received in 2020 and £4.2 million in 2019. The alcohol industry suffered disruptions during the pandemic-induced lockdowns worldwide.

Earlier this year, Cobra Beer announced a total dividend of £5 million.

Lord Bilimoria’s spokesperson told The Times: “As before, the vast majority of the dividends has been used to settle creditors.”

The peer, 60, planned to continue to settle remaining creditors from his share of the dividends “over the remaining years of the joint venture”, the spokesperson said.

More For You

NHS

NHS ranks among worst for treatable deaths despite £242 billion spending

Getty Images

NHS ranks among worst for treatable deaths despite £242 billion spending

  • UK ranks among worst for treatable mortality, ahead of only US in global analysis.
  • NHS spending has reached £242 billion, but infrastructure gaps persist.
  • Shortage of scanners, beds and delays in care continue to affect outcomes.

The NHS is facing renewed scrutiny after a major international analysis suggested that UK patient survival rates remain among the weakest in developed healthcare systems, despite record levels of spending.

The report, led by the Institute for Public Policy Research, found that the UK ranks near the bottom among 22 countries for treatable mortality, a measure of deaths that could potentially be avoided with timely and effective care. Only the US performed worse.

Keep ReadingShow less